Healthcare
Live Price
Offline$0.006
+0.00% today
1Y Change
-80.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Petros Pharmaceuticals, Inc. (PTPI) is a Healthcare stock with listed on NASDAQ. The stock last traded around $0.01 and down 80.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +304.2%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +304.2%, free cash flow -180418.8% with operating margin 0.0% and ROIC 68.7%. Valuation is more restrained than many high-expectation growth names at P/E 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PTPI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PTPI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PTPI Max Drawdown
-85.71%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PTPI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
-100.0%
EPS Growth
+304.2%
Gross Margin
0.0%
Net Margin
0.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.